The FTSE 100 index closed up 24.59 points, 0.3%, at 8,875.22, just shy of its record closing peak of 8,884.92 posted last ...

This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...

With this quintet of FTSE 100 stocks, an investor would have portfolio exposure stretching from the Americas and Europe to ...

CINCINNATI ( Cincinnati Business Courier) - Backed by big money and aggressive plans to manufacture cutting-edge gene and ...

The thing that I worry about more than loss of exclusivity is this term that I introduced at the AACR meeting -- loss of relevancy" says Susan Galbraith, EVP of Oncology R&D at AstraZeneca.

Cancer researchers discovered how exercise really can be like a drug for colon cancer, and AstraZeneca's immunotherapy drug ...

US stock futures slipped after the Trump administration’s trade talks with China ended with thinly detailed outcomes.